reported the clinical features of 10 patients carrying DNAAF3 mutations, with each patient displaying typical symptoms of PCD, including chronic cough, recurrent chest infections, sinusitis, severe lung disease, bronchiectasis, and hearing loss.19 Here, DNAAF3 is linked to lung disorder.